Vistagen Therapeutics, Inc. financial data

Symbol
VTGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
343 Allerton Avenue, South San Francisco, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
Excaliber Enterprises, Ltd. (to 6/8/2011)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.99K % +235%
Debt-to-equity 8.14 % -81.3%
Return On Equity -36.4 % +80.7%
Return On Assets -33.6 % +74.4%
Operating Margin 26.1K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.8M shares +3.04%
Entity Public Float 62.7M USD +101%
Common Stock, Value, Issued 27K USD +125%
Weighted Average Number of Shares Outstanding, Basic 30.6M shares +205%
Weighted Average Number of Shares Outstanding, Diluted 30.6M shares +205%

Income Statement

Label TTM Value / Value Unit Change %
Revenues -227K USD -120%
Research and Development Expense 29.8M USD +23.1%
General and Administrative Expense 16.6M USD +34.7%
Operating Income (Loss) -45.6M USD -27.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -39.6M USD -11.5%
Income Tax Expense (Benefit) 8K USD +100%
Net Income (Loss) Attributable to Parent -39.6M USD -11.5%
Earnings Per Share, Basic -0.69 USD/shares +85.4%
Earnings Per Share, Diluted -0.42 USD/shares +36.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.2M USD +124%
Cash, Cash Equivalents, and Short-term Investments 97.6M USD
Assets, Current 99.9M USD +156%
Property, Plant and Equipment, Net 467K USD +5.11%
Operating Lease, Right-of-Use Asset 1.58M USD -22.6%
Other Assets, Noncurrent 498K USD
Assets 102M USD +143%
Accounts Payable, Current 715K USD -45.2%
Employee-related Liabilities, Current 17.3K USD -92.8%
Accrued Liabilities, Current 3.82M USD +1204%
Contract with Customer, Liability, Current 2.47M USD +211%
Liabilities, Current 7.52M USD +159%
Contract with Customer, Liability, Noncurrent 730K USD -59%
Operating Lease, Liability, Noncurrent 1.27M USD -31.6%
Liabilities 9.52M USD +45.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 22K USD
Retained Earnings (Accumulated Deficit) -380M USD -11.6%
Stockholders' Equity Attributable to Parent 93M USD +161%
Liabilities and Equity 102M USD +143%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -37.7%
Net Cash Provided by (Used in) Financing Activities 88K USD -89.9%
Net Cash Provided by (Used in) Investing Activities -5.47M USD
Common Stock, Shares Authorized 325M shares 0%
Common Stock, Shares, Issued 27.1M shares +125%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.2M USD -132%
Deferred Tax Assets, Valuation Allowance 60.5M USD +2.14%
Deferred Tax Assets, Gross 60.5M USD +2.17%
Operating Lease, Liability 2.12M USD -18.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.9M USD -96.4%
Lessee, Operating Lease, Liability, to be Paid 2.45M USD -22%
Property, Plant and Equipment, Gross 1.69M USD -0.65%
Operating Lease, Liability, Current 525K USD +1.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 732K USD +3.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 710K USD +2.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 329K USD -38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 753K USD +2.94%
Deferred Tax Assets, Operating Loss Carryforwards 46.5M USD +6.56%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.93M USD +284%
Lessee, Operating Lease, Liability, to be Paid, Year Four 254K USD -66.3%
Operating Lease, Payments 223K USD +8.83%
Additional Paid in Capital 477M USD +25.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 34K USD +6.25%
Deferred Tax Assets, Net of Valuation Allowance 20K USD +300%
Share-based Payment Arrangement, Expense 3.3M USD +32%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%